Literature DB >> 20084551

Spatiotemporal patterns of dexamethasone-induced Ras protein 1 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.

Heng Gao1, Ying Gao, Xiaohong Li, Aiguo Shen, Meijuan Yan.   

Abstract

Dexamethasone-induced Ras protein 1 (Dexras 1), a brain-enriched member of Ras subfamily of guanosine triphosphatases, as a novel physiologic nitric oxide (NO) effector, anchor neuronal nitric oxide synthase (nNOS) that could form a ternary complex with carboxy-terminal PDZ ligand of nNOS (CAPON) and nNOS, to specific targets to enhance NO signaling. The present study was to explore the expression pattern of Dexras 1 in the development of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. Western blot and immunochemistry analysis showed that the gene and protein expression of Dexras 1 in the central nervous system (CNS) of rats increased significantly during the process of EAE compared with control groups (p < 0.01) and maintain a high level in the remission period. The protein expressions of nNOS and CAPON in hippocampus were approximately paralleled Dexras 1. Immunofluorescence revealed that both neurons and glial cells expressed the Dexras 1 in EAE CNS. Importantly, the damaged CNS in EAE-affected rats showed the codistribution between Dexras 1 and caspase 3, indicating the role of Dexras 1 played in the apoptotic process in EAE. Furthermore, colocalizations of Dexras 1 were observed in neurons and glial cells in CNS with nNOS or CAPON, supporting the ternary complex in this model. Thus, these findings suggest the postulation that Dexras 1 might participate into CNS neuronal cell death and demyelination in the whole process of EAE through regulating the NO signaling by binding to nNOS and CAPON.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084551     DOI: 10.1007/s12031-009-9322-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  41 in total

1.  Demyelinating diseases--new pathological insights, new therapeutic targets.

Authors:  S G Waxman
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 2.  Neural roles for heme oxygenase: contrasts to nitric oxide synthase.

Authors:  D E Barañano; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Modulation of basal hepatic glycogenolysis by nitric oxide.

Authors:  M Borgs; M Bollen; S Keppens; S H Yap; W Stalmans; F Vanstapel
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

4.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease.

Authors:  Shailendra Giri; Manu Jatana; Ramandeep Rattan; Je-Seong Won; Inderjit Singh; Avtar K Singh
Journal:  FASEB J       Date:  2002-05       Impact factor: 5.191

6.  Changes in mRNA for CAPON and Dexras1 in adult rat following sciatic nerve transection.

Authors:  Aiguo Shen; Mengling Chen; Shuqiong Niu; Linlin Sun; Shangfeng Gao; Shuxian Shi; Xin Li; Qingshan Lv; Zhiqin Guo; Chun Cheng
Journal:  J Chem Neuroanat       Date:  2007-07-31       Impact factor: 3.052

7.  Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats.

Authors:  K Wada; K Chatzipanteli; S Kraydieh; R Busto; W D Dietrich
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

8.  Blockade of nitric oxide formation by N omega-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats.

Authors:  T Nagafuji; T Matsui; T Koide; T Asano
Journal:  Neurosci Lett       Date:  1992-12-07       Impact factor: 3.046

9.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

10.  Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.

Authors:  Y Vodovotz; M S Lucia; K C Flanders; L Chesler; Q W Xie; T W Smith; J Weidner; R Mumford; R Webber; C Nathan; A B Roberts; C F Lippa; M B Sporn
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Research progress on neurobiology of neuronal nitric oxide synthase.

Authors:  Chun-Xia Luo; Dong-Ya Zhu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

2.  Upregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis.

Authors:  Jang-Mi Park; Yoo-Jin Shin; Jeong Min Cho; Jae-Youn Choi; Sin-Soo Jeun; Jung-Ho Cha; Mun-Yong Lee
Journal:  J Histochem Cytochem       Date:  2012-09-13       Impact factor: 2.479

3.  Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.

Authors:  Haoyu Wang; Jing Yuan; Xiaoqian Dang; Zhibin Shi; Wenrui Ban; Dong Ma
Journal:  Cell Biosci       Date:  2021-03-11       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.